Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin Dosages in Severe Aplastic Anemia
NCT01844635Phase 3Unknown
- Sponsor
- Nagoya University
- Start
- May 2012
- Primary completion
- May 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of antithymocyte globulin in aplastic anemia, sponsored by Nagoya University. Status: unknown.
02
Drugs
antithymocyte globulin
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT01844635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01844635.